From Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/25046234

Abstract

BACKGROUND:

Excess subcutaneous fat causes not only cosmetic issues, but also substantial systemic health problems. Cryolipolysis has been reported to provide non-invasive fat reduction that significantly reduces subcutaneous fat cells with controlled, localized cooling.

OBJECTIVE:

This study is intended to determine whether a cryolipolysis device can effectively reduce subcutaneous fat without damaging the overlying skin or causing significant side effects and ultimately produce improved cosmetic results.

MATERIALS AND METHODS:

A total of 15 patients participated in this study and they were treated unilaterally in a split-body trial manner with a non-invasive cryolipolysis device (Micool(™), Hironic Co., Seongnam, Korea). The degree of improvement was assessed by both objective and subjective assessments. Complications and side effects were recorded at every visit.

RESULTS:

The results of both objective and subjective assessments showed significant improvements in subcutaneous fat reduction without any meaningful complications.

CONCLUSION:

Non-invasive selective cryolipolysis has been reported to be a safe and effective treatment modality for the reduction of excess adipose tissue. Therefore, cryolipolysis is a promising technology that could be an appropriate and safe therapeutic option for subcutaneous fat reduction.

KEYWORDS:

cryolipolysis; fat removal